Institutional Biosafety Committee (IBC)
In accordance with the National Institutes of Health (NIH) Guidelines, the National
Cancer Institute-Frederick (NCI-F) has established an Institutional Biosafety Committee
(IBC) . The committee represents the interests of the surrounding community with
respect to public health and protection of the environment, animal containment principles
and biological safety.
The IBC is responsible for reviewing projects that involve, but are not limited to:
rDNA/RNA; RNAi (shRNA/siRNA); Pathogens; Oncogenes; Biological Toxins; Human Materials;
Other potentially infectious material (OPIM); Transgenic or Knock-Out/In Animals;
Synthetic Biology; Nanotechnology; and Dual Use Materials.